Čájehuvvojit 1 - 6 oktiibuot 6 bohtosis ohcui Gabriele Morani (15038018)', ohcanáigi: 0,01s
Aiddostahte ozu
-
1
Figure 3 from Impact of Duration of Neoadjuvant Aromatase Inhibitors on Molecular Expression Profiles in Estrogen Receptor–positive Breast Cancers Dahkki Milana A. Bergamino (15038015)
Almmustuhtton 2025Eará dahkkit: “…Gabriele Morani (15038018)…”
-
2
Figure 4 from Impact of Duration of Neoadjuvant Aromatase Inhibitors on Molecular Expression Profiles in Estrogen Receptor–positive Breast Cancers Dahkki Milana A. Bergamino (15038015)
Almmustuhtton 2025Eará dahkkit: “…Gabriele Morani (15038018)…”
-
3
Figure 2 from Impact of Duration of Neoadjuvant Aromatase Inhibitors on Molecular Expression Profiles in Estrogen Receptor–positive Breast Cancers Dahkki Milana A. Bergamino (15038015)
Almmustuhtton 2025Eará dahkkit: “…Gabriele Morani (15038018)…”
-
4
Figure 5 from Impact of Duration of Neoadjuvant Aromatase Inhibitors on Molecular Expression Profiles in Estrogen Receptor–positive Breast Cancers Dahkki Milana A. Bergamino (15038015)
Almmustuhtton 2025Eará dahkkit: “…Gabriele Morani (15038018)…”
-
5
Figure 1 from Impact of Duration of Neoadjuvant Aromatase Inhibitors on Molecular Expression Profiles in Estrogen Receptor–positive Breast Cancers Dahkki Milana A. Bergamino (15038015)
Almmustuhtton 2025Eará dahkkit: “…Gabriele Morani (15038018)…”
-
6
Figure 6 from Impact of Duration of Neoadjuvant Aromatase Inhibitors on Molecular Expression Profiles in Estrogen Receptor–positive Breast Cancers Dahkki Milana A. Bergamino (15038015)
Almmustuhtton 2025Eará dahkkit: “…Gabriele Morani (15038018)…”